147 related articles for article (PubMed ID: 22965958)
1. Tale of two lymphomas: peripheral T-cell lymphoma after allogeneic stem-cell transplantation for marginal zone lymphoma.
Lee L; Lipton JH; Bailey D; Kukreti V
J Clin Oncol; 2012 Nov; 30(31):e309-11. PubMed ID: 22965958
[No Abstract] [Full Text] [Related]
2. Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation.
Kahl C; Leithäuser M; Wolff D; Steiner B; Hartung G; Casper J; Freund M
Ann Hematol; 2002 Nov; 81(11):646-50. PubMed ID: 12454703
[TBL] [Abstract][Full Text] [Related]
3. The role of high-dose chemotherapy and autologous stem cell transplant for treatment-naΪve patients with peripheral T-cell lymphoma: a systematic review of the literature.
Jethwa KD; Bishton MJ; Fox CP
Br J Haematol; 2017 Aug; 178(3):476-479. PubMed ID: 27146257
[No Abstract] [Full Text] [Related]
4. Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Fetscher S; Lübbert M; Kanz L; Behringer D; Finke J; Mertelsmann R; Lange W
Bone Marrow Transplant; 1997 Mar; 19(5):527-8. PubMed ID: 9052926
[TBL] [Abstract][Full Text] [Related]
5. Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas.
Bishop MR; Hou JW; Wilson WH; Steinberg SM; Odom J; Castro K; Kasten-Sportes C; Gea-Banacloche J; Marchigiani D; Gress R; Fowler DH
Biol Blood Marrow Transplant; 2003 Mar; 9(3):162-9. PubMed ID: 12652466
[TBL] [Abstract][Full Text] [Related]
6. High-dose therapy and stem cell transplantation.
Zinzani PL
Semin Hematol; 2010 Apr; 47 Suppl 1():S15-7. PubMed ID: 20359581
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic cell transplant for relapsed-refractory, marginal zone lymphoma: a single-center experience.
Dholaria BR; Hammond WA; Roy V; Sher T; Vishnu P; Soyano A; Finn LE; Tun H
Leuk Lymphoma; 2018 Nov; 59(11):2727-2730. PubMed ID: 29566563
[No Abstract] [Full Text] [Related]
8. Metachronous extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) and peripheral T-cell lymphoma unspecified: histologic, immunophenotypic, and molecular documentation.
Venizelos J; Papadopoulos N; Lambropoulou M; Nikolaidou S; Bolioti S; Tamiolakis D
Onkologie; 2005 Aug; 28(8-9):423-6. PubMed ID: 16160405
[TBL] [Abstract][Full Text] [Related]
9. Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory marginal zone lymphoma.
Yamasaki S; Chihara D; Yoshida I; Kohda K; Sawa M; Ago H; Togitani K; Ohno Y; Tanaka J; Fukuda T; Atsuta Y; Suzumiya J; Suzuki R
Ann Hematol; 2019 Jun; 98(6):1521-1523. PubMed ID: 30560447
[No Abstract] [Full Text] [Related]
10. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.
Blystad AK; Enblad G; Kvaløy S; Berglund A; Delabie J; Holte H; Carlson K; Kvalheim G; Bengtsson M; Hagberg H
Bone Marrow Transplant; 2001 Apr; 27(7):711-6. PubMed ID: 11360110
[TBL] [Abstract][Full Text] [Related]
11. [Six cases of pulmonary MALT lymphoma: a heterogeneous therapeutic management].
Marco S; Thariat J; Poudenx M; Butori C; Mouroux J; Fuzibet JG; Marquette CH; Peyrade F; Thyss A
Rev Pneumol Clin; 2011 Jun; 67(3):174-8. PubMed ID: 21665083
[TBL] [Abstract][Full Text] [Related]
12. [Biology and treatment of indolent lymphomas: follicular lymphoma and marginal zone B-cell lymphoma].
Nishikori M
Rinsho Ketsueki; 2009 Oct; 50(10):1332-41. PubMed ID: 19915340
[No Abstract] [Full Text] [Related]
13. Composite marginal zone B cell lymphoma and enteropathy-type T cell lymphoma of the stomach: a case report.
Yun WK; Ko YH; Kim DS; Kim WS; Rhee PL; Kwak SY; Jang TH; Choi WS
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):791-5. PubMed ID: 18617785
[TBL] [Abstract][Full Text] [Related]
14. FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame.
Ashizawa M; Kako S; Wada H; Sakamoto K; Sato M; Terasako K; Kimura S; Kikuchi M; Nakasone H; Okuda S; Yamazaki R; Oshima K; Nishida J; Kanda Y
Hematol Oncol; 2012 Mar; 30(1):50-2. PubMed ID: 21574175
[No Abstract] [Full Text] [Related]
15. [Diagnosis and treatment of peripheral T-cell lymphoma].
Suzumiya J; Moriyama I; Kawakami K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():519-24. PubMed ID: 23134009
[No Abstract] [Full Text] [Related]
16. Lymphoma of the colon.
Romaguera J; Hagemeister FB
Curr Opin Gastroenterol; 2005 Jan; 21(1):80-4. PubMed ID: 15687889
[TBL] [Abstract][Full Text] [Related]
17. Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy.
Alpen B; Kuse R; Parwaresch R; Müller-Hermelink HK; Stolte M; Neubauer A
J Clin Oncol; 2004 Aug; 22(15):3039-45. PubMed ID: 15284253
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of adult T-cell leukemia/lymphoma: progresses in the chemotherapy and stem cell transplantation].
Tsukasaki K
Rinsho Ketsueki; 2004 Mar; 45(3):195-201. PubMed ID: 15103932
[No Abstract] [Full Text] [Related]
19. [Recent progress in the treatment of malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
[TBL] [Abstract][Full Text] [Related]
20. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.
Rodríguez J; Conde E; Gutiérrez A; Arranz R; Gandarillas M; Leon A; Ojanguren J; Sureda A; Carrera D; Bendandi M; Moraleda J; Ribera JM; Albo C; Morales A; García JC; Fernández P; Cañigral G; Bergua J; Caballero MD;
Eur J Haematol; 2007 Apr; 78(4):290-6. PubMed ID: 17378891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]